Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Cerebrospinal fluid (CSF) levels of tau proteins, a-synuclein, and β-amyloid 1-42 (Aβ1-42) appear to be associated with early stage Parkinson disease (PD) in a group of untreated patients compared with healthy patients, according to a study by Ju-Hee Kang, M.D., of the University of Pennsylvania, and colleagues.
The study included the initial 102 research volunteers (63 patients with PD and 39 healthy control patients) of the Parkinson's Progression Markers Initiative (PPMI) study.
Results indicate that slightly, but significantly, lower levels of Aβ1-42, T-tau, P-tau 181 , a-synuclein and T-tau/Aβ1-42 were seen in patients with PD compared with healthy control patients. Lower Aβ1-42 and P-tau 181 levels were associated with PD diagnosis, and decreased CSF T-tau and a-synuclein levels were associated with increased motor severity, the results also show.
"In this first report of CSF biomarkers in PPMI study subjects, we found that measures of CSF Aβ1-42, T-tau, P-tau 181 and a-synuclein have prognostic and diagnostic potential in early-stage PD. Further investigations using the entire PPMI cohort will test the predictive performance of CSF biomarkers for PD progression," the study concludes.
JAMA Neurol. Published online August 26, 2013. doi:10.1001/.jamaneurol.2013.3861.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Parkinson's Disease category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
JAMA. "Study examines cerebrospinal fluid biomarkers in early Parkinson disease." Medical News Today. MediLexicon, Intl., 29 Aug. 2013. Web.
6 Dec. 2013. <http://www.medicalnewstoday.com/releases/265369>
JAMA. (2013, August 29). "Study examines cerebrospinal fluid biomarkers in early Parkinson disease." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265369.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.